New York, NY – February 13, 2015 – VR1, Inc. announces the availability of Ausanil®, a new non-prescription homeopathic nasal spray specifically formulated by neurologist and VR1 founder Dr. Anjan Chatterjee to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions. Achieving rapid pain relief is a significant challenge for millions of people with headaches and migraine, one of the top 10 most disabling conditions in the U.S.





Developed by a Neurologist to Treat His Own Migraines, Ausanil Homeopathic Nasal Spray Is  Now Available to Headache Sufferers Nationwide  

VR1-IncNew York, NY – February 13, 2015 – VR1, Inc. announces the availability of Ausanil®, a new non-prescription homeopathic nasal spray specifically formulated by neurologist and VR1 founder Dr. Anjan Chatterjee to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions. Achieving rapid pain relief is a significant challenge for millions of people with headaches and migraine, one of the top 10 most disabling conditions in the U.S.

“We are pleased to offer Ausanil as an important new option for severe headache and migraine patients still searching for a treatment that is effective, safe and accessible,” said lifelong migraine sufferer Dr. Chatterjee. “As a physician who has treated thousands of headache patients, and as a lifelong migraine sufferer myself, I know how frustrating and debilitating it can be when you are unable to function in your daily life because you have to wait so long for your medication to take effect.”


Approximately one-third of the 36 million migraine sufferers in the U.S. are not satisfied with their current treatment regimen. Ausanil was developed to address several of the biggest challenges for millions of sufferers, including inadequate pain relief and side effect limitations.

Dr. Chatterjee drew from decades of direct patient care and extensive experience in neuroscience drug development to develop Ausanil. Specifically formulated to provide rapid relief, when used as directed, Ausanil can be taken multiple times per day, alone or with other migraine medications, without reported risk of systemic side effects or drug-drug interactions. Ausanil is non-habit forming and does not contain caffeine, zinc, aspirin or acetaminophen. Dr. Chatterjee uses Ausanil to successfully treat his own migraines, achieving pain relief within a matter of minutes.


An Unmet Medical Need 

Many current treatments for severe headaches and migraine have limitations for many patients due to a variety of factors, including: onset of effect (some medications require up to an hour or more to achieve significant effect), side effects (such as gastrointestinal ulcers, liver damage and risk of dependence), and potential adverse interactions with other medications, including antidepressants and blood thinners. Certain treatments may also be contraindicated for those with heart disease or a family history of heart disease or diabetes.

American Headache Society guidelines generally advise against using prescription therapies, specifically opioids, as first-line treatment for migraine due to risk of dependency. The guidelines also warn that commonly used over-the-counter (OTC) pain relievers should not be used more than twice weekly due to an increase in “medication overuse headache” as well as potential liver, kidney and stomach issues.

“Severe headaches and migraine represents a significant unmet medical need as there are few new treatment options available to sufferers to help them get back to their lives quickly when pain strikes,” said Dr. Chatterjee. “As a safe, homeopathic product, Ausanil does not pose the common challenges patients can face, such as debilitating side effects, drug-drug interactions and contraindications for specific conditions including heart, kidney and liver disease.”

Many users have reported rapid pain relief with Ausanil. Individual experience will vary.


How Ausanil Works  

Ausanil works by acting locally on a receptor on the sensory nerve cells in the nose to ultimately reduce pain. When administered, a local stinging sensation in the nasal cavity indicates the sensory nerve has been stimulated, which leads to a reduction in the release of pain molecules in the brain. It is believed that this decrease in pain molecules leads to a reduction in swelling and inflammation of blood vessels surrounding the brain, resulting in pain relief. Ausanil treatment acts locally in the nose and only small quantities are needed for rapid pain relief, so that it does not interact with other medications and can be taken as often as needed. More details on how Ausanil works to relieve headache pain can be found here.

Non-prescription Ausanil is available now at select pharmacies throughout the U.S. and at Ausanil.com. Each bottle retails for $34.95 and contains approximately 50 doses—less than 70 cents per dose.


About Ausanil 

Ausanil was developed as a non-prescription homeopathic nasal spray treatment to provide rapid relief from severe headache and migraine pain. When used in accordance with directions, Ausanil is safe to use several times daily without systemic side effects or adverse drug interactions. Ausanil may also be an effective treatment option for cluster headaches, chronic daily headaches, frequent tension headaches and medication overuse headaches.

Specifically formulated for severe headaches and migraines, Ausanil should not be used for mild or infrequent headaches, sinus headaches, atypical migraines, basilar migraines, migraines with abdominal symptoms, or any new onset severe headaches that are unusual for the sufferer. New onset headaches that are severe and come on suddenly require immediate medical attention. Ausanil should not be used in people with an active nasal infection, active and symptomatic asthma or upper respiratory tract infection, or with a severely deviated nasal septum. Ausanil is not recommended for women who are pregnant or breastfeeding, or for patients under age 18. People allergic to any of the listed ingredients should not use Ausanil.

While Ausanil is available without a prescription, it’s important that patients always discuss using Ausanil and its incorporation into their current treatment regimens with their doctors.


About Dr. Anjan Chatterjee  

Board certified in Neurology and Psychiatry, Dr. Anjan Chatterjee has more than two decades of direct patient care experience, treating patients with a wide variety of neurological and psychiatric disorders. Over the last decade, Dr. Chatterjee has worked at Merck Research Labs and Pfizer to develop neuroscience medicines.  

He is an elected Fellow of the American Headache Society (AHS) and the American Psychiatric Association (APA), an honor and a mark of recognition by his peers of his contribution to the fields of neurology and psychiatry. Dr. Chatterjee is a member of several professional organizations, including the American Academy of Neurology (AAN), AHS, Movement Disorders Society (MDS), APA, American Medical Association (AMA) and American Association of Family Practice Physicians (AAFP). He has presented peer reviewed research at multiple medical conferences in the U.S. and across Europe and has authored multiple research manuscripts published in peer reviewed medical journals, including Movement Disorders, Headache, Cephalalgia, Journal of Neurology Neurosurgery and Psychiatry, Biological Psychiatry, Journal of Clinical Psychopharmacology and the American Journal of Psychiatry. He is also a reviewer for several peer reviewed medical journals, including Neurobiology of Disease, Journal of Neurology Neurosurgery and Psychiatry, Psychiatry Research and Movement Disorders. Dr. Chatterjee graduated Medical School from the University of Delhi, India, earned a Master’s in Public Health (Epidemiology and Biostatistics) from Columbia University, and has a Master of Business Administration from Columbia Business School.

About VR1, Inc.   

VR1 is committed to meeting the needs of patients by providing therapeutic solutions that are effective, safe and accessible. Founded by neurologist Dr. Anjan Chatterjee, VR1 focuses on providing treatments to address acute pain associated with migraine and other severe headache conditions.  


For further information: 

Reena Patel, Ausanil Media Relations


919.381.6702, media@ausanil.com